Home » Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance

Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance

October 28, 2013

Senesco has enrolled its first patients at a new clinical trial site in Seattle. The company is beginning a Phase Ib/IIa trial of its SNS01-T drug for B-cell cancer.
Pharmaceutical Business Review

27Jan
Medical Device Clinical Trials in China: Latest Regulatory Developments
27Jan
FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations
09Feb
Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19
10Feb
FDA Under the Biden Administration: What’s to Come and What It Will Mean
11Feb
Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era
17Feb
Effective Auditing for Manufacturing Quality

Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance

Upcoming Events

Medical Device Clinical Trials in China: Latest Regulatory Developments

FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations

Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19

FDA Under the Biden Administration: What’s to Come and What It Will Mean

Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

Effective Auditing for Manufacturing Quality

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

Regeneron’s Antibody Cocktail Shows Efficacy as COVID-19 Treatment

FDA to Review Berkshire’s 510(k) Submission for Remote Drug-Delivery System

Desidustat Improves Oxygenation for Hospitalized COVID-19 Patients

Abbott’s Panbio COVID-19 Test Gets Additional CE Marks

The Revised ICH E8: A Guide to New Clinical Trial Requirements